查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571960

全球心臟义肢假体市场

Cardiac Prosthetic Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟义肢假体市场将达到 119 亿美元

2023年全球心臟义肢假体市场估计为74亿美元，预计2030年将达到119亿美元，2023-2030年分析期间复合年增长率为7.2%。植入式心律调节器是本报告分析的细分市场之一，预计复合年增长率为 7.7%，到分析期结束时将达到 47 亿美元。分析期间，体外心律调节器市场的复合年增长率预计为 6.8%。

美国市场预估成长19亿美元，中国复合年增长率10.7%

到 2023 年，美国心臟义肢假体市场预计将达到 19 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达29亿美元，2023-2030年分析期间复合年增长率为10.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.5% 和 6.4%。在欧洲，德国的复合年增长率预计为 4.3%。

全球心臟义肢假体市场－主要趋势与驱动因素总结

什么是心臟义肢假体？

心臟义肢假体是用于支持或替换心臟受损或失效部件的医疗植入，为患有各种心臟疾病的患者提供挽救生命的解决方案。这些设备，包括心臟瓣膜、心律调节器、心臟去颤器和辅助人工心臟(VAD)，在结构性心臟病、心律不整和心臟衰竭的治疗中发挥至关重要的作用。随着全球心血管疾病（CVD）盛行率的不断增加，特别是心臟瓣膜疾病和心臟衰竭，心臟义肢假体在现代心臟病学中变得至关重要。

心臟瓣膜置换术是最常进行的心臟义肢假体手术之一。透过用机械或生物瓣膜替换有缺陷的瓣膜来解决瓣膜狭窄和反流等问题。心律调节器和植入式心臟整流去颤器(ICD) 等设备有助于管理异常心律，辅助人工心臟可支持等待心臟移植的患者或患有晚期心臟衰竭的患者的心臟功能。心血管疾病仍然是全世界死亡的主要原因，因此心臟义肢假体对于改善受影响患者的生活品质和生存至关重要。

科技进步如何形塑心臟义肢假体市场？

技术进步透过提高设备性能、患者治疗效果和手术成功率正在彻底改变心臟义肢假体市场。材料科学的创新促进了更耐用和生物相容性心臟瓣膜的开发。例如，新型机械瓣膜的设计具有更长的使用寿命，从而减少了翻修手术的需要。另一方面，生物瓣膜通常源自于动物组织，不需要长期使用血液稀释剂，凝血风险较低。此外，经导管心臟瓣膜置换术，例如经导管主动脉瓣置换术（TAVR），正在获得巨大的关注。 TAVR 是一种微创手术，无需进行心臟直视手术即可进行瓣膜置换术，从而减少恢復时间和相关风险。无导线心律调节器较小，更容易植入，因此感染疾病和其他併发症的风险较小。同样，下一代 ICD 将具有增强的编程功能，以更好地检测和治疗危及生命的心律不整，从而改善患者的治疗结果。此外，辅助人工心臟的进步使得这些装置更小、更可靠且更容易在晚期心臟衰竭患者中进行管理。远端监控和无线连接等数位健康技术的整合可实现即时病患监测、设备併发症的早期检测以及更好的植入后护理，从而进一步推动心臟义肢假体市场的发展。

哪些患者和医疗保健趋势正在推动心臟义肢假体的需求？

一些医疗保健和患者趋势正在推动心臟义肢假体需求的成长。这是因为老年人更容易罹患心血管疾病，尤其是瓣膜性心臟病和心臟衰竭。随着预期寿命的不断延长，对心臟瓣膜置换术、心律调节器和其他心臟装置的需求也不断增加。此外，被诊断为先天性心臟疾病或早发性心血管疾病的年轻患者也受益于提供长期解决方案的义肢装置的进步，而这些装置适用于各种年龄层的患者，这对于患者来说变得极为重要。

另一个重要趋势是人们越来越偏好微创手术。患者越来越多地寻求恢復更快、併发症更少、住院时间更短的治疗方法。 TAVR、经导管二尖瓣瓣环成形(TMVR) 和微创心律调节器植入等技术正在满足这一需求，使更多患者能够接受挽救生命的手术，而无需承担与心臟直视手术相关的风险。随着这些手术变得越来越广泛，心臟义肢假体也变得越来越容易被更多人所接受。

此外，对以患者为中心的护理的日益关注以及数位医疗的兴起正在影响需求。患者和医疗保健提供者现在可以使用允许远端监控的设备，从而实现更好的术后追踪和个人化护理。这些进步将进一步推动对心臟义肢假体的需求，以改善慢性病管理、减少再入院率并提高患者满意度。

心臟义肢假体市场的成长受到多种因素的推动。

心臟义肢假体市场的成长受到多种因素的推动，包括心血管疾病盛行率的上升、人口老化的加剧以及医疗技术的进步。主要因素之一是心臟瓣膜疾病和心律不整的发生率增加，尤其是老年人。随着瓣膜性心臟病随着老龄化的增长而变得越来越常见，对机械和生物人工心臟瓣膜的需求也不断增加。 TAVR 等微创手术因其风险低、恢復时间快而越来越受欢迎，为市场扩张做出了巨大贡献。

技术进步也是推动成长的重要因素。无导线心律调节器、可扩展 ICD 和微型辅助人工心臟等创新正在改善患者的治疗效果并扩大适合治疗的患者范围。将心臟义肢假体与数位健康工具整合的能力可以对慢性心血管疾病患者进行即时监测和更好的管理，使这些设备对患者和医疗保健提供者都更加有效。

此外，对预防性医疗保健和早期诊断的日益关注导致越来越多地采用心臟义肢假体作为综合心血管护理策略的一部分。新兴市场医疗保健基础设施的扩张，加上人们对心臟健康意识的增强，也为市场创造了新的机会。随着世界各地的医疗保健系统努力应对日益增加的心血管疾病负担，对先进、耐用和患者友好的心臟义肢假体的需求预计将继续增长。

受访企业范例（共42例）

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21436

Global Cardiac Prosthetic Devices Market to Reach US$11.9 Billion by 2030

The global market for Cardiac Prosthetic Devices estimated at US$7.4 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Implantable Pacemakers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the External Pacemakers segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 10.7% CAGR

The Cardiac Prosthetic Devices market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cardiac Prosthetic Devices Market – Key Trends & Drivers Summarized

What Are Cardiac Prosthetic Devices, and Why Are They Crucial for Cardiac Care?

Cardiac prosthetic devices are medical implants used to support or replace damaged or failing components of the heart, offering life-saving solutions for patients with various heart conditions. These devices include heart valves, pacemakers, defibrillators, and ventricular assist devices (VADs), which play a pivotal role in managing structural heart diseases, arrhythmias, and heart failure. With the rising global incidence of cardiovascular diseases (CVDs), especially heart valve disorders and heart failure, cardiac prosthetic devices have become critical in modern cardiology.

Heart valve replacements are among the most commonly used cardiac prosthetic devices. They address issues like valve stenosis or regurgitation by replacing faulty valves with mechanical or biological alternatives. Devices like pacemakers and implantable cardioverter defibrillators (ICDs) help manage abnormal heart rhythms, while VADs are used to support heart function in patients awaiting heart transplants or for those with advanced heart failure. As cardiovascular disease remains the leading cause of death worldwide, cardiac prosthetic devices are essential for improving the quality of life and survival rates of affected patients.

How Are Technological Advancements Shaping the Cardiac Prosthetic Devices Market?

Technological advancements are revolutionizing the cardiac prosthetic devices market by improving device performance, patient outcomes, and procedural success rates. Innovations in materials science have led to the development of more durable and biocompatible heart valves. For instance, newer mechanical valves are designed to last a lifetime, reducing the need for repeat surgeries, while biological valves, often derived from animal tissue, offer a lower risk of clotting without requiring long-term blood thinners. Additionally, transcatheter heart valve replacement technologies, such as transcatheter aortic valve replacement (TAVR), have gained significant traction. TAVR is a minimally invasive procedure that allows valve replacement without the need for open-heart surgery, reducing recovery time and associated risks. Leadless pacemakers, which are smaller and easier to implant, offer less risk of infection and other complications. Similarly, next-generation ICDs come with enhanced programming to better detect and treat life-threatening arrhythmias, improving patient outcomes. Furthermore, advancements in VADs are making these devices more compact, reliable, and easier to manage for patients with advanced heart failure. The integration of digital health technologies, such as remote monitoring and wireless connectivity, is enabling real-time patient monitoring, early detection of device complications, and better post-implant care, further advancing the cardiac prosthetic devices market.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Prosthetic Devices?

Several healthcare and patient trends are driving the growing demand for cardiac prosthetic devices. The aging global population is one of the primary factors, as older individuals are more susceptible to cardiovascular diseases, particularly valvular heart diseases and heart failure. As life expectancy continues to rise, the need for heart valve replacements, pacemakers, and other cardiac devices is also increasing. Additionally, younger patients diagnosed with congenital heart defects or early-onset cardiovascular conditions are benefiting from advancements in prosthetic devices that offer long-term solutions, making these devices crucial for patients across various age groups.

Another significant trend is the rising preference for minimally invasive procedures. Patients are increasingly seeking treatments that offer quicker recovery times, fewer complications, and shorter hospital stays. Technologies like TAVR, transcatheter mitral valve repair (TMVR), and minimally invasive pacemaker implantation cater to this demand, enabling more patients to undergo life-saving procedures without the risks associated with open-heart surgery. The expanding availability of these procedures in more regions is making cardiac prosthetic devices accessible to a broader population.

Moreover, the growing focus on patient-centric care and the rise of digital health are influencing demand. Patients and healthcare providers now have access to devices that allow for remote monitoring, enabling better post-procedure follow-up and personalized care. These advancements improve the management of chronic conditions, reduce hospital readmissions, and enhance patient satisfaction, further driving demand for cardiac prosthetic devices.

Growth in the Cardiac Prosthetic Devices Market Is Driven by Several Factors

Growth in the cardiac prosthetic devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing aging population, and advancements in medical technologies. One of the key drivers is the increasing incidence of heart valve disorders and arrhythmias, particularly among older adults. As heart valve disease becomes more common with age, the demand for prosthetic heart valves, both mechanical and biological, is rising. Minimally invasive procedures like TAVR are gaining popularity due to their lower risks and faster recovery times, contributing significantly to market expansion.

Technological advancements are another crucial factor driving growth. Innovations such as leadless pacemakers, enhanced ICDs, and compact VADs are improving patient outcomes and expanding the range of patients eligible for treatment. The ability to integrate cardiac prosthetic devices with digital health tools is enabling real-time monitoring and better management of patients with chronic cardiovascular conditions, making these devices more effective and appealing to both patients and healthcare providers.

Additionally, the growing focus on preventive healthcare and early diagnosis is increasing the adoption of cardiac prosthetic devices as part of comprehensive cardiovascular care strategies. The expansion of healthcare infrastructure in developing regions, coupled with increased awareness about heart health, is also creating new opportunities for the market. As healthcare systems worldwide work to address the growing burden of cardiovascular diseases, the demand for advanced, durable, and patient-friendly cardiac prosthetic devices is expected to continue its upward trajectory.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Prosthetic Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Material Science and Biocompatibility Enhance the Development of Cardiac Prosthetic Devices
    • Rising Global Prevalence of Heart Diseases Propels the Demand for Cardiac Prosthetics
    • Technological Innovations in Prosthetic Valves Improve Durability and Functional Outcomes
    • Increasing Adoption of Minimally Invasive Procedures Boosts Market Growth for Cardiac Prosthetics
    • Growth in Geriatric Population Worldwide Drives the Need for Advanced Cardiac Prosthetic Solutions
    • Expansion of Healthcare Infrastructure in Emerging Markets Opens New Opportunities for Cardiac Prosthetics
    • Patient-Specific Implants and Customization Using 3D Printing Technology Propel Market Innovations
    • Integration of Smart Sensors in Prosthetic Devices Enhances Post-Operative Monitoring and
    • Ethical and Legal Issues Surrounding the Use of Advanced Prosthetic Devices in Cardiology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for External Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Cardiac Prosthetic Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Spain 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Russia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Australia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: India 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: South Korea 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Argentina 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Brazil 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Mexico 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Iran 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Israel 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Saudi Arabia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UAE 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Africa 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030

IV. COMPETITION